ARTICLE | Clinical News
Cubist target validation technology
January 17, 2000 8:00 AM UTC
CBST developed peptides that bind to potential pathogen targets, combined with inducible expression of the peptides in a virulent bacterial strain, to validate targets derived from genomics. Expressio...